SpringWorks Therapeutics, a subsidiary of Merck KGaA based in Darmstadt, Germany, announced that the European Commission has approved OGSIVEO for adults with progressing desmoid tumors
Biocon Biologics Ltd , a fully integrated global biosimilars company and subsidiary of Biocon Ltd., announced that the European Commission (EC) has granted marketing authorisation in the
Ultragenyx Pharmaceutical, a biopharmaceutical company focused on the development and commercialisation of novel therapies for rare and ultrarare genetic diseases, announced that the European Commission
Fuel up with free Health Tech Insights
